Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alana Welm

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2004
Cell division and cell survival in the absence of survivinDun Yang, Alana Welm, J Michael Bishop
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2007
Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathwayAmi S Bhatt, Alana Welm, Christopher J Farady, et al.
Cell Reports|June 2, 2021
Inhibiting an RBM39/MLL1 epigenomic regulatory complex with dominant-negative peptides disrupts cancer cell transcription and proliferationPavan Kumar Puvvula, Yao Yu, Kaelan Renaldo Sullivan, et al.
The Journal of Clinical Investigation|December 12, 2017
Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasisQi Sun, Jacqueline Lesperance, Hiromi Wettersten, et al.
Nature Communications|February 17, 2017
A class of extracellular vesicles from breast cancer cells activates VEGF receptors and tumour angiogenesisQiyu Feng, Chengliang Zhang, David Lum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2016
High Intratumoral Stromal Content Defines Reactive Breast Cancer as a Low-risk Breast Cancer SubtypeJennifer B Dennison, Maria Shahmoradgoli, Wenbin Liu, et al.
Cancer Discovery|December 16, 2016
Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast CancersSarah Naomi Olsen, Ania Wronski, Zafira Castaño, et al.
Cancer Cell|January 8, 2021
An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment PersistenceEugen Dhimolea, Ricardo de Matos Simoes, Dhvanir Kansara, et al.
Cancer Metastasis Reviews|December 28, 2016
Patient-derived xenograft (PDX) models in basic and translational breast cancer researchLacey E Dobrolecki, Susie D Airhart, Denis G Alferez, et al.
Medicina|June 27, 2025
Buenos Aires Breast Cancer Symposium 2024: bridging basic and clinical research in breast cancerMartín Abba, Fariba Behbod, Paolo Ceppi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2004
Cell division and cell survival in the absence of survivinDun Yang, Alana Welm, J Michael Bishop
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2007
Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathwayAmi S Bhatt, Alana Welm, Christopher J Farady, et al.
Cell Reports|June 2, 2021
Inhibiting an RBM39/MLL1 epigenomic regulatory complex with dominant-negative peptides disrupts cancer cell transcription and proliferationPavan Kumar Puvvula, Yao Yu, Kaelan Renaldo Sullivan, et al.
The Journal of Clinical Investigation|December 12, 2017
Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasisQi Sun, Jacqueline Lesperance, Hiromi Wettersten, et al.
Nature Communications|February 17, 2017
A class of extracellular vesicles from breast cancer cells activates VEGF receptors and tumour angiogenesisQiyu Feng, Chengliang Zhang, David Lum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2016
High Intratumoral Stromal Content Defines Reactive Breast Cancer as a Low-risk Breast Cancer SubtypeJennifer B Dennison, Maria Shahmoradgoli, Wenbin Liu, et al.
Cancer Discovery|December 16, 2016
Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast CancersSarah Naomi Olsen, Ania Wronski, Zafira Castaño, et al.
Cancer Cell|January 8, 2021
An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment PersistenceEugen Dhimolea, Ricardo de Matos Simoes, Dhvanir Kansara, et al.
Cancer Metastasis Reviews|December 28, 2016
Patient-derived xenograft (PDX) models in basic and translational breast cancer researchLacey E Dobrolecki, Susie D Airhart, Denis G Alferez, et al.
Medicina|June 27, 2025
Buenos Aires Breast Cancer Symposium 2024: bridging basic and clinical research in breast cancerMartín Abba, Fariba Behbod, Paolo Ceppi, et al.
Pageof 2